<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05046769</url>
  </required_header>
  <id_info>
    <org_study_id>102-20</org_study_id>
    <nct_id>NCT05046769</nct_id>
  </id_info>
  <brief_title>COVID-19: A Scope Research on Epidemiology and Clinical Course</brief_title>
  <acronym>COVID-Scope</acronym>
  <official_title>COVID-19: A Scope Research on Epidemiology and Clinical Course</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Saude Publica da Universidade do Porto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centro Hospitalar De São João, E.P.E.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Saude Publica da Universidade do Porto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV) 2 infection and the associated&#xD;
      coronavirus disease 2019 (COVID-19) are the most recent international health threat&#xD;
      challenging our ability to protect populations, to avoid severe outcomes and to understand&#xD;
      both the population dynamics of this new condition and the breath of individual responses.&#xD;
      Gathering information on the clinical course of the disease and the risk of transmission is&#xD;
      essential to design effective therapeutic solutions and preventive measures. The aim of the&#xD;
      study proposed, to be carried out at University Hospital Center of &quot;São João&quot; (CHUSJ), is to&#xD;
      recruit and follow-up a cohort of patients diagnosed with SARS-CoV-2 infection, to evaluate&#xD;
      the clinical course of SARS-CoV-2 infection and COVID-19 cases, to identify prognostic&#xD;
      factors and to measure the risk of reinfection. Additionally, researchers intend to&#xD;
      characterize the patients and household contacts to describe the dynamics of infection, to&#xD;
      calculate household infection attack rate, and to perform the genetic sequencing of&#xD;
      SARS-CoV-2 to understand determinants of disease course (namely long-term effects) and risk&#xD;
      of household transmission. A sample of participants, identified during the process of&#xD;
      evaluation of symptomatic individuals, at the same institution, and negative for SARS-CoV-2&#xD;
      will be selected as negative controls.&#xD;
&#xD;
      Participants will be consecutively recruited and the study is expected to enroll patients as&#xD;
      long as the pandemic remains. Information will be gathered based on clinical individual&#xD;
      charts, hospital data-bases (example: for administrative data) and individual computer&#xD;
      assisted interviews to be performed at pre-defined intervals (3, 12 and 24 months) or&#xD;
      according to clinical needs.&#xD;
&#xD;
      The project was approved by the local Ethical Committee and the Data Protection relevant&#xD;
      authorities.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical, biological, psychosocial characteristics</measure>
    <time_frame>24 months</time_frame>
    <description>Describe the clinical, biological and psychosocial characteristics SARS-CoV-2 infected inpatients or outpatients identified in our hospital center</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Household contacts infection attack rate</measure>
    <time_frame>3 months</time_frame>
    <description>Characterize the dynamics of infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genome sequence of SARS-CoV-2</measure>
    <time_frame>24 months</time_frame>
    <description>Identify variants of SARS-CoV-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinfection rate</measure>
    <time_frame>24 months</time_frame>
    <description>Number and characteristics of reinfections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic factors of course of disease</measure>
    <time_frame>24 months</time_frame>
    <description>Identify clinical, biological and social associated with course of disease</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Covid19</condition>
  <condition>SARS CoV 2 Infection</condition>
  <condition>Sequelae of; Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with SARS-CoV-2 infection diagnosed at Centro Hospitalar Universitário&#xD;
        São João, a level III hospital center, from March 1, 2020. A sample of individuals who&#xD;
        underwent the test for diagnosis of infection by SARS-CoV-2 with negative result.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals diagnosed with SARS-2-CoV-2 infection treated at CHUSJ and cohabitants&#xD;
             able to give informed consent;&#xD;
&#xD;
          -  individuals who underwent the test for diagnosis of infection by SARS-CoV-2 at CHUSJ&#xD;
             with negative result able to give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to obtain informed consent;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margarida Tavares, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Hospitalar Universitário São João &amp; ISPUP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margarida Tavares, MD, MPH</last_name>
    <phone>+351222061820</phone>
    <email>mftavares@ispup.up.pt</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro Hospitalar De São João</name>
      <address>
        <city>Porto</city>
        <zip>4200-319</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarida Tavares</last_name>
      <phone>+351225512389</phone>
      <email>margarida.tavares@chsj.min-saude.pt</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Saude Publica da Universidade do Porto</investigator_affiliation>
    <investigator_full_name>Margarida Fernandes Tavares</investigator_full_name>
    <investigator_title>Senior researcher</investigator_title>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>Cohort Studies</keyword>
  <keyword>Long COVID</keyword>
  <keyword>Secondary Attack Rate</keyword>
  <keyword>Serology</keyword>
  <keyword>Epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

